-
- 抗原 See all LMTK3 抗体
- LMTK3 (Lemur Tyrosine Kinase 3 (LMTK3))
-
抗原表位
- AA 156-187, N-Term
-
适用
- 人, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This LMTK3 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Flow Cytometry (FACS)
- 纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 免疫原
- This LMTK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 156-187 amino acids from the N-terminal region of human LMTK3.
- 亚型
- Ig Fraction
- Top Product
- Discover our top product LMTK3 Primary Antibody
-
-
- 应用备注
-
For WB starting dilution is: 1:1000-1,2000
For FACS starting dilution is: 1:10~50 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer." in: Molecular therapy. Oncology, Vol. 32, Issue 3, pp. 200864, (2024) (PubMed).
: "
-
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer." in: Molecular therapy. Oncology, Vol. 32, Issue 3, pp. 200864, (2024) (PubMed).
-
-